Drug Pipeline

Human Umbilical Cord Mesenchymal Stem Cells Injection Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
3
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-05 NCT07628933 A Phase I Trial of Umbilical Cord Mesenchymal Stromal Cells for Acute Ischemic Stroke Phase 1 Not Yet Recruiting
Active Studies by Phase
Phase 1/2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07413549 Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With… Decompensated Hepatitis B Cirrhosis Recruiting
NCT07452822 Safety and Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells in Preventing… Arteriovenous Fistula Stenosis Not Yet Recruiting
Phase 1
NCT07628933 A Phase I Trial of Umbilical Cord Mesenchymal Stromal Cells for Acute Ischemic Stroke Acute Ischemic Stroke Not Yet Recruiting
Sponsors Running Human Umbilical Cord Mesenchymal Stem Cells Injection Trials
Beijing Tuohua Weiye Biotechnology Co., Ltd. (1) Jiangsu Topcel-KH Pharmaceutical Co., Ltd. (1) BOE Technology Group Co., Ltd. (1)
Disease Areas
Stroke (1)
Get alerts when Human Umbilical Cord Mesenchymal Stem Cells Injection trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free